Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03547973
Title Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Immunomedics, Inc.
Indications

transitional cell carcinoma

Therapies

Sacituzumab govitecan-hziy

Age Groups: senior | adult
Covered Countries USA | FRA


No variant requirements are available.